PHOTO
Dubai: As part of an affiliation agreement between Mediclinic Middle East and Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) for the training of medical students, the first group of 49 fourth-year medical students was yesterday welcomed to Mediclinic Middle East in an inaugural ceremony which marked their arrival and celebrated the progression of their studies.
The students will now commence their clinical clerkship in Mediclinic Middle East’s hospitals and clinics in Dubai, joining the departments of Family Medicine, Surgery, Paediatrics, Internal Medicine and Dermatology in rotation over a 40-week period per year. Once they have completed their full six-year course, including their clerkships at Mediclinic, students will have attained an MBBS degree and be eligible to enter a UAE residency programme or undertake postgraduate studies overseas.
Professor Alawi Alsheikh Ali, Dean of the College of Medicine at MBRU said, “We are very proud of our students who have worked hard over the past three years to be ready for this phase of their learning experience at MBRU. We are fortunate to have a strong and mutually beneficial affiliation with Mediclinic and the Ministry of Health and Prevention who have been very supportive of the educational journey of our students. Together, we are working towards advancing the academic care model in Dubai and the UAE."
Dr. Leon Du Preez, Senior Corporate Medical Director at Mediclinic Middle East and Honorary Associate Dean for Academic Partnerships said: “We are delighted to welcome this first group of students as part of an affiliation with MBRU which I hope will last for many years. Working together in this way, we are able to support the United Arab Emirates’ long term vision of training the next generation of doctors and medical professionals for the challenges posed by a rapidly evolving healthcare landscape.”
-Ends-
About Mediclinic Middle East
Mediclinic Middle East is part of Mediclinic International, a private hospital group with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates, and a 29.9% shareholding in Spire Healthcare, a UK-based healthcare group with 38 hospitals.
Mediclinic Middle East operates seven hospitals and 20 clinics with over 900 inpatient beds in the United Arab Emirates.
Mediclinic puts science at the heart of its care approach, focusing on providing the best possible facilities with international-standard technology, backed-up by sound medical expertise and the empathy of its nursing staff. For further information about Mediclinic Middle East and its facilities visit www.mediclinic.ae.
Contact:
Arun Avamil
Mediclinic Middle East
Tel: + 97144495285/Email: info[at]mediclinic.ae
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
